Boehringer Ingelheim Investigational Site

Madrid

0 studies enrolling now · 3 studies all time

What they study most

Diabetes Mellitus, Type 2, HIV Infections, Pulmonary Disease, Chronic Obstructive

Studies at this site

• 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study — Completed
• MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin — Completed
• Tiotropium / Respimat One-Year Study — Completed